Topical dorzolamide may have some effect in reducing central macular thickness in patients with XLRS, but this does not necessarily correlate with improvement in VA.
多佐胺在黄斑中心变薄的X连锁视网膜剥离患者可能有一定的治疗效果，但这与视觉灵敏度的改善没有必要的关联性。
Topical dorzolamide may have some effect in reducing central macular thickness in patients with XLRS, but this does not necessarily correlate with improvement in VA.
多佐胺在黄斑中心变薄的X连锁视网膜剥离患者可能有一定的治疗效果，但这与视觉灵敏度的改善没有必要的关联性。
应用推荐